ImpriMed Launches Advanced Precision Medicine Service for Canine Blood Cancers
ImpriMed, Inc., a biotech startup, officially introduced its drug response prediction service earlier this month to the veterinary oncology space in the U.S.ImpriMed, Inc., a biotech startup, officially introduced its drug response prediction service earlier this month to the veterinary oncology space in the U.S.